Recent news on Eskalith

• Books: Southern Discomfort  -  Apr 20, 2007
NewsweekBut let’s put it in purely medicinal terms: “This is what it takes to get me through the day: 450 milligrams of Eskalith, 1000 milligrams of Neurontin,

Agitation in the Elderly  -  Feb 16, 2007
Psychiatric Times,1988), antihistamines and lithium carbonate (Eskalith, Lithobid). With antihistamines, however, there is a risk of anticholinergic confusion.

Multiple Medication Use in General Practice and Psychiatry: So ...  Aug 23, 2006
For example, ibuprofen, an OTC analgesic, can cause serious and even life-threatening elevations in lithium (Eskalith, Lithobid) levels by affecting its rate ... -Psychiatric Times

STAR*D ‘Diligent Delivery of Care’ Model Yields Remission ...  Jun 20, 2006
Options at Level 3 were mirtazapine (Remeron) or nortriptyline (Aventyl, Pamelor) as monotherapies or augmentation with lithium (Eskalith, Lithobid) or a ... -Psychiatric Times



Behavioral and Pharmacologic Treatment of Aggression in Children ...  May 10, 2006
Case reports and a retrospective review have reported on the use of lithium (Eskalith, Lithobid) or divalproex (Depakote) for aggressive behaviors in youth ... - Psychiatric Times





FDA-Approved Office Lithium Test Expected To Enhance Clinical Care  Mar 24, 2006
Since the 1970s, lithium (Eskalith, Lithobid) has been a mainstay of treatment for bipolar disorder (BD) and an effective augmentation strategy for treatment ... - Psychiatric Times

Treatment Compliance in Patients With Co-Occurring Mental Illness ...  Mar 15, 2006
...(1998), compliance was significantly associated with treatment with divalproex (Depakote), compared to treatment with combined lithium (Eskalith, Lithobid). ... - Psychiatric Times

Managing Treatment-Resistant OCD  Mar 14, 2006
Despite promising case reports, lithium (Eskalith, Lithobid) did not prove to be efficacious in two double-blind, placebo-controlled trials (McDougle et al ... - Psychiatric Times

STAR*D Preliminary Findings Provide Clearer Picture of Major ...  Mar 14, 2006
3. Options at Level 3 were mirtazapine (Remeron) or nortriptyline (Aventyl, Pamelor) as monotherapies, or augmentation with lithium (Eskalith, Lithobid) or a ... - Psychiatric Times

STAR*D Preliminary Findings Provide Clearer Picture of Major ...  Feb 27, 2006
3. Options at Level 3 were mirtazapine (Remeron) or nortriptyline (Aventyl, Pamelor) as monotherapies, or augmentation with lithium (Eskalith, Lithobid) or a ... - Psychiatric Times,

Preventing and Reducing Professional Liability Risk Related to ...  Jan 12, 2006
...standards and guidelines for the monitoring of many psychotropic medications (eg, clozapine [Clozaril], lithium [Eskalith, Lithobid], antidepressants). ... - Psychiatric Times

Treatment Compliance in Patients With Co-Occurring Mental Illness ...  Jan 23, 2006
...(1998), compliance was significantly associated with treatment with divalproex (Depakote), compared to treatment with combined lithium (Eskalith, Lithobid). ... - Psychiatric Times

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional